Images |
Sources |
Experiment + Assay |
Phenotypes |
Human Diseases |
|
Fig. 4 J, Sup. Fig. 2 A D
Neilson KM et al. (2020)
|
Xla Wt + mcrs1
NF13-18 (in situ hybridization)
|
|
|
|
Fig. 5 B
Neilson KM et al. (2020)
|
Xla Wt + mcrs1
NF13-18 (in situ hybridization)
|
|
|
|
Fig. 6 E col 4
Neilson KM et al. (2020)
|
Xla Wt + mcrs1
NF13-18 (in situ hybridization)
|
|
|
|
Fig. 7 H J
Neilson KM et al. (2020)
|
Xla Wt + mcrs1
NF28-33/34 (in situ hybridization)
|
|
|
|
Fig. 6 E col 3
Neilson KM et al. (2020)
|
Xla Wt + mcrs1 + six1 MO
NF13-18 (in situ hybridization)
|
|
|
|
Fig. 2 J N Q
Neilson KM et al. (2020)
|
Xla Wt + mcrs1 MO
NF13-18 (in situ hybridization)
|
|
|
|
Fig. 5 G col1
Neilson KM et al. (2020)
|
Xla Wt + mcrs1 MO
NF13-18 (in situ hybridization)
|
|
|
|
Fig. 7 B D
Neilson KM et al. (2020)
|
Xla Wt + mcrs1 MO
NF28-33/34 (in situ hybridization)
|
|
|
|
Fig. 5 B
Neilson KM et al. (2020)
|
Xla Wt + six1
NF13-18 (in situ hybridization)
|
|
|
|
Fig. 5 B
Neilson KM et al. (2020)
|
Xla Wt + six1 + mcrs1
NF13-18 (in situ hybridization)
|
|
|